Caprock Group’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,582
Closed -$216K 724
2023
Q4
$216K Buy
+2,582
New +$216K 0.01% 632